You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 5,585,115


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,585,115
Title: Pharmaceutical excipient having improved compressability
Abstract:A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.
Inventor(s): Sherwood; Bob E. (Amenia, NY), Hunter; Edward A. (Glenham, NY), Staniforth; John H. (Bath, GB2)
Assignee: Edward H. Mendell Co., Inc. (Patterson, NY)
Application Number:08/370,576
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

United States Patent 5,585,115: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 5,585,115, titled "Pharmaceutical excipient having improved compressibility," is a significant patent in the pharmaceutical industry, particularly in the field of excipients. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent, granted on December 17, 1996, describes a microcrystalline cellulose-based excipient with enhanced compressibility. This excipient is designed for use in various pharmaceutical formulations, including direct compression, dry granulation, and wet granulation processes[4].

Assignee and Inventors

The patent is assigned to JRS Pharma LP, with the inventors listed as Sherwood et al.

Scope of the Patent

Claims

The patent includes several claims that define the scope of the invention. Key claims include:

  • The composition of the excipient, which is a microcrystalline cellulose-based material.
  • The improved compressibility characteristics of the excipient.
  • The methods of preparing the excipient, including specific processing steps to achieve the desired compressibility[4].

Prior Art and Background

The patent references several prior art patents and publications that highlight the need for improved excipients in pharmaceutical formulations. It also discusses the limitations of existing excipients and how the new invention addresses these issues[4].

Claims Analysis

Independent Claims

The independent claims define the core aspects of the invention. For example, Claim 1 describes the composition of the excipient, specifying the use of microcrystalline cellulose and other components that enhance compressibility[4].

Dependent Claims

Dependent claims further detail the invention by specifying additional features or limitations. These claims often describe specific methods of preparation, additional components, or particular applications of the excipient.

Patent Landscape Analysis

Defining Scope and Keywords

To analyze the patent landscape, one must first define the scope and relevant keywords. For this patent, keywords include "microcrystalline cellulose," "pharmaceutical excipient," "compressibility," and "pharmaceutical formulations"[3].

Search and Organize Patents

Using databases such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and other international patent databases, one can retrieve relevant patents related to these keywords. Organizing these patents by factors like filing date, assignee, and technology subcategories helps in understanding the evolution of the technology[1][3].

Identify Trends and Key Players

The analysis reveals trends in patent filings related to pharmaceutical excipients. Key players in this field include JRS Pharma LP, as well as other companies and research institutions that have filed patents on similar or related technologies. This step helps in identifying competitors and potential collaborators[3].

Analyze Citations and Evolution

Studying how patents reference each other provides insights into the impact and development of the technology. For example, the patent 5,585,115 is cited by several subsequent patents, indicating its influence on later innovations in the field[3].

Generate Insights for Decisions

The analysis translates into practical guidance for strategic decisions. It helps in evaluating the competitive landscape, identifying potential legal vulnerabilities, and understanding the strength of the patent portfolio. This information is crucial for inventors and companies looking to innovate or enter the market[3].

Key Players and Competitors

JRS Pharma LP

As the assignee of the patent, JRS Pharma LP is a significant player in the field of pharmaceutical excipients. Their portfolio includes several patents related to microcrystalline cellulose and other excipient technologies[4].

Other Competitors

Other companies and research institutions have also filed patents in this domain. For instance, patents by inventors like Staniforth et al. and Hunter et al. indicate a competitive and innovative environment in the pharmaceutical excipient market[2].

Technological Trends

Advancements in Compressibility

The patent landscape shows a trend towards improving the compressibility of pharmaceutical excipients. This is driven by the need for more efficient and stable pharmaceutical formulations. Recent patents have focused on various methods to enhance compressibility, including new processing techniques and material combinations[3].

Global Patent Activity

The global patent activity in this field is significant, with contributions from various international intellectual property offices. Databases like PATENTSCOPE by WIPO and esp@cenet by the EPO provide access to a wide range of international patents, highlighting global trends and innovations[1].

Legal and Regulatory Considerations

Patent Validity and Enforcement

When evaluating the patent 5,585,115, it is crucial to consider its legal status and any potential challenges. The patent's validity can be assessed by examining the prosecution history, the patent specification, and the literal language of the claims. Courts consider these factors when construing patent claims[5].

International Protection

Given the global nature of pharmaceutical research and development, understanding international patent protection is essential. Tools like the Global Dossier and the Common Citation Document (CCD) help in managing and analyzing patent families across different jurisdictions[1].

Conclusion

The United States Patent 5,585,115 is a pivotal invention in the field of pharmaceutical excipients, offering improved compressibility and enhancing the efficiency of pharmaceutical formulations. Through a detailed patent landscape analysis, one can gain insights into the competitive landscape, technological trends, and key players in this domain. This information is invaluable for inventors, researchers, and companies seeking to innovate and protect their intellectual property.

Key Takeaways

  • The patent 5,585,115 describes a microcrystalline cellulose-based excipient with improved compressibility.
  • The scope of the patent includes specific claims related to the composition and preparation of the excipient.
  • A patent landscape analysis reveals trends in pharmaceutical excipient technology and identifies key players.
  • Understanding the legal and regulatory aspects of the patent is crucial for its enforcement and protection.
  • Global patent activity and international protection mechanisms are important considerations in this field.

FAQs

What is the main invention described in United States Patent 5,585,115?

The main invention is a microcrystalline cellulose-based pharmaceutical excipient with improved compressibility.

Who are the key players in the field of pharmaceutical excipients?

Key players include JRS Pharma LP and other companies and research institutions that have filed patents on similar technologies.

How can one conduct a patent landscape analysis for this patent?

One can conduct a patent landscape analysis by defining the scope and keywords, searching and organizing relevant patents, identifying trends and key players, analyzing citations and evolution, and generating insights for strategic decisions.

What are the legal considerations for enforcing this patent?

Legal considerations include examining the prosecution history, the patent specification, and the literal language of the claims, as well as understanding the patent's validity and any potential challenges.

How does international patent protection impact this invention?

International patent protection is crucial as it involves managing and analyzing patent families across different jurisdictions using tools like the Global Dossier and the Common Citation Document (CCD).

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. United States Patent 6,753,017 B2: https://patentimages.storage.googleapis.com/37/48/4f/cbdc9a9ada078a/US6753017.pdf
  3. How to Do Patent Landscape Analysis: https://www.goldsteinpatentlaw.com/how-to-patent-landscape-analysis/
  4. US5585115A - Pharmaceutical excipient having improved compressability: https://patents.google.com/patent/US5585115A/en
  5. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT: https://www.govinfo.gov/content/pkg/USCOURTS-ded-1_19-cv-01727/pdf/USCOURTS-ded-1_19-cv-01727-1.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,585,115

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 5,585,115

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 4759896 ⤷  Try for Free
Australia 5019996 ⤷  Try for Free
Australia 5830399 ⤷  Try for Free
Austria 239450 ⤷  Try for Free
Austria 441403 ⤷  Try for Free
Austria 445391 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.